Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
PI3Kα inactivation in leptin receptor cells increases leptin sensitivity but disrupts growth and reproduction
David Garcia-Galiano, Beatriz C. Borges, Jose Donato Jr., Susan J. Allen, Nicole Bellefontaine, Mengjie Wang, Jean J. Zhao, Kenneth M. Kozloff, Jennifer W. Hill, Carol F. Elias
David Garcia-Galiano, Beatriz C. Borges, Jose Donato Jr., Susan J. Allen, Nicole Bellefontaine, Mengjie Wang, Jean J. Zhao, Kenneth M. Kozloff, Jennifer W. Hill, Carol F. Elias
View: Text | PDF
Research Article Reproductive biology

PI3Kα inactivation in leptin receptor cells increases leptin sensitivity but disrupts growth and reproduction

  • Text
  • PDF
Abstract

The role of PI3K in leptin physiology has been difficult to determine due to its actions downstream of several metabolic cues, including insulin. Here, we used a series of mouse models to dissociate the roles of specific PI3K catalytic subunits and of insulin receptor (InsR) downstream of leptin signaling. We show that disruption of p110α and p110β subunits in leptin receptor cells (LRΔα+β) produces a lean phenotype associated with increased energy expenditure, locomotor activity, and thermogenesis. LRΔα+β mice have deficient growth and delayed puberty. Single subunit deletion (i.e., p110α in LRΔα) resulted in similarly increased energy expenditure, deficient growth, and pubertal development, but LRΔα mice have normal locomotor activity and thermogenesis. Blunted PI3K in leptin receptor (LR) cells enhanced leptin sensitivity in metabolic regulation due to increased basal hypothalamic pAKT, leptin-induced pSTAT3, and decreased PTEN levels. However, these mice are unresponsive to leptin’s effects on growth and puberty. We further assessed if these phenotypes were associated with disruption of insulin signaling. LRΔInsR mice have no metabolic or growth deficit and show only mild delay in pubertal completion. Our findings demonstrate that PI3K in LR cells plays an essential role in energy expenditure, growth, and reproduction. These actions are independent from insulin signaling.

Authors

David Garcia-Galiano, Beatriz C. Borges, Jose Donato Jr., Susan J. Allen, Nicole Bellefontaine, Mengjie Wang, Jean J. Zhao, Kenneth M. Kozloff, Jennifer W. Hill, Carol F. Elias

×

Figure 5

LRΔα females show decreased bone volume and bone mineral density.

Options: View larger image (or click on image) Download as PowerPoint
LRΔα females show decreased bone volume and bone mineral density.
(A) No...
(A) Normal body length at P40 in LRΔα (n = 11) mice with respect to αfl mice (n = 12; t17 = 0.31, P = 0.76), with reduced body length relative to αfl mice at P60 (αfl, n = 15; LRΔα, n = 14; t21 = 5.2, P < 0.0001). (B) Relative mRNA expression of growth hormone–releasing hormone (GHRH; t9 = 1.94, P = 0.085) and somatostatin (SST) in the mediobasal hypothalamus (MBH) and growth hormone (GH) and GH receptor (GHR) in pituitary. GHR (t10 = 2.38, P = 0.039), insulin-like growth factor 1 (IGF1; n = 5–6/group; t10 = 2.47, P = 0.033) and fibroblast growth factor 21 (FGF21) liver. (C) Similar circulating Igf-1 levels at P40 (αfl, n = 9; LRΔα, n = 6; t14 = 1.46, P = 0.17) and P60 (n = 6-7/group; t10 = 1.67, P = 0.13). (D) Representative images of trabecular (Tb) and cortical (Ct) femora. (E) Reduced percentage of bone volume/total volume (Tb.BV/TV; t10 = 2.53, P = 0.03), (F) thickness (t10 = 4.76, P = 0.0008), and (G) bone mineral density (Tb.BMD; t10 = 2.78, P = 0.02) in LRΔα mice versus control females. (H) Similar trabecular number (Tb.Number; t10 = 0.31, P = 0.3) and (I) spacing between genotypes (t10 = 1.19, P = 0.26). Reduced cortical (J) BV/TV (t10 = 2.39, P = 0.038), (K) thickness (t10 = 2.23, P = 0.05), and (L) area in LRΔα females (t10 = 2.31, P = 0.043). No differences in (M) marrow area (t10 = 0.3, P = 0.77) or (N) total area (t10 = 1.84, P = 0.1, n = 6/group). Each point represents 1 individual mouse. Data are presented as mean ± SEM. *P ≤ 0.05, **P < 0.01; by 2-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts